215 related articles for article (PubMed ID: 16470222)
21. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
22. RhoA and p38 MAPK mediate apoptosis induced by cellular cholesterol depletion.
Calleros L; Lasa M; Rodríguez-Alvarez FJ; Toro MJ; Chiloeches A
Apoptosis; 2006 Jul; 11(7):1161-73. PubMed ID: 16699960
[TBL] [Abstract][Full Text] [Related]
23. Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation.
Dechend R; Gieffers J; Dietz R; Joerres A; Rupp J; Luft FC; Maass M
Circulation; 2003 Jul; 108(3):261-5. PubMed ID: 12860900
[TBL] [Abstract][Full Text] [Related]
24. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.
Lai TH; Fong YC; Fu WM; Yang RS; Tang CH
Prostate; 2008 Sep; 68(12):1341-53. PubMed ID: 18512729
[TBL] [Abstract][Full Text] [Related]
25. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells.
Cafforio P; Dammacco F; Gernone A; Silvestris F
Carcinogenesis; 2005 May; 26(5):883-91. PubMed ID: 15705602
[TBL] [Abstract][Full Text] [Related]
26. Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma.
Tsubaki M; Yamazoe Y; Yanae M; Satou T; Itoh T; Kaneko J; Kidera Y; Moriyama K; Nishida S
Cytokine; 2011 Apr; 54(1):100-7. PubMed ID: 21292498
[TBL] [Abstract][Full Text] [Related]
27. The extracellular calcium-sensing receptor reciprocally regulates the secretion of BMP-2 and the BMP antagonist Noggin in colonic myofibroblasts.
Peiris D; Pacheco I; Spencer C; MacLeod RJ
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G753-66. PubMed ID: 17138967
[TBL] [Abstract][Full Text] [Related]
28. ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells.
Moosavi MA; Yazdanparast R; Lotfi A
Int J Biochem Cell Biol; 2007; 39(9):1685-97. PubMed ID: 17543571
[TBL] [Abstract][Full Text] [Related]
29. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.
Tang D; Park HJ; Georgescu SP; Sebti SM; Hamilton AD; Galper JB
Life Sci; 2006 Sep; 79(15):1484-92. PubMed ID: 16740276
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
31. Simvastatin reduces lipoprotein-associated phospholipase A2 in lipopolysaccharide-stimulated human monocyte-derived macrophages through inhibition of the mevalonate-geranylgeranyl pyrophosphate-RhoA-p38 mitogen-activated protein kinase pathway.
Song JX; Ren JY; Chen H
J Cardiovasc Pharmacol; 2011 Feb; 57(2):213-22. PubMed ID: 21052011
[TBL] [Abstract][Full Text] [Related]
32. Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs.
Fromigué O; Hamidouche Z; Marie PJ
J Pharmacol Exp Ther; 2008 May; 325(2):595-600. PubMed ID: 18252811
[TBL] [Abstract][Full Text] [Related]
33. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
34. Requirement of the JNK-associated Bcl-2 pathway for human lactoferrin-induced apoptosis in the Jurkat leukemia T cell line.
Lee SH; Park SW; Pyo CW; Yoo NK; Kim J; Choi SY
Biochimie; 2009 Jan; 91(1):102-8. PubMed ID: 18534198
[TBL] [Abstract][Full Text] [Related]
35. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
Wu JB; Fong YC; Tsai HY; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jul; 588(2-3):333-41. PubMed ID: 18495116
[TBL] [Abstract][Full Text] [Related]
36. Relationship of bone morphogenetic protein expression during osteoblast differentiation to wild type p53.
Chandar N; Swindle J; Szajkovics A; Kolman K
J Orthop Res; 2005 Nov; 23(6):1345-53. PubMed ID: 15994055
[TBL] [Abstract][Full Text] [Related]
37. Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion.
Fromigué O; Hamidouche Z; Marie PJ
J Biol Chem; 2008 Nov; 283(45):30549-56. PubMed ID: 18757369
[TBL] [Abstract][Full Text] [Related]
38. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
39. Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK/MAPK pathway.
German OL; Insua MF; Gentili C; Rotstein NP; Politi LE
J Neurochem; 2006 Sep; 98(5):1507-20. PubMed ID: 16923163
[TBL] [Abstract][Full Text] [Related]
40. CREB transcription factor modulates Bcl2 transcription in response to C5a in HL-60-derived neutrophils.
Perianayagam MC; Madias NE; Pereira BJ; Jaber BL
Eur J Clin Invest; 2006 May; 36(5):353-61. PubMed ID: 16634840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
